Thromb Haemost 1993; 69(05): 531
DOI: 10.1055/s-0038-1651652
Letter to the Editor
Schattauer GmbH Stuttgart

Spontaneous Versus Secondary Thrombosis in Congenital Heterozygous Plasminogen Deficiency – Rebuttal

T Shigekiyo
The First Department of Internal Medicine, School of Medicine, The University of Tokushima, Tokushima, Japan
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 01. Februar 1993

Accepted after revision 01. Februar 1993

Publikationsdatum:
25. Juli 2018 (online)

 
  • References

  • 1 Shigekiyo T, Uno Y, Tomonari A, Satoh K, Hondo H, Ueda S, Saito S. Type I congenital plasminogen deficiency is not a risk factor for thrombosis. Thromb Haemostas 1992; 67: 189-192
  • 2 Mannucci PM, Kluft C, Traas DW, Seveso P, D’Angelo A. Congenital plasminogen deficiency associated with venous thromboembolism: therapeutic trial with stanozolol. Br J Haematol 1986; 63: 753-759
  • 3 Dolan G, Greaves M, Cooper P, Preston FE. Thrombovascular disease and familial plasminogen deficiency: a report of three kindreds. Br J Haematol 1988; 70: 417-421
  • 4 Shigekiyo T, Tomonari A, Uno Y, Kishi Y. Danazol therapy in hypoplasminogenemia. Thromb Haemostas 1992; 68: 233-234